Immunic reported $188.76M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
BioMarin Pharmaceutical USD 3.92B 50.99M Sep/2026
Cipla INR 250.61B 9.14B Sep/2026
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 129.41M 7.88M Jun/2026
CSL USD 11.85B 1000K Dec/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 188.76M 165.89M Mar/2026
Insmed USD 1.71B 72.59M Sep/2026
Omeros USD 69.65M 26.53M Jun/2025
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.45B 69.4M Sep/2026
Ultragenyx Pharmaceutical USD 544M 62M Sep/2026
United Therapeutics USD 2.88B 603.5M Sep/2026